Orchard Bio Co., Ltd. announces that in May 2024, a joint research agreement is signed with Dr. Akihiko Taguchi, the Department of Regenerative Medicine Research at the Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovative at Kobe (FBRI), regarding hAP cells, useful in the treatment of ischemic diseases.
Through this collaboration, we will further expand the capabilities of the hAP cells.
